SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

PGC Paragon Care Limited

Healthcare · Medical Distribution · website
$0.14
52wk 0.12 – 0.33
Overall
32.4
Value
68.8
Growth
50.0
Health
13.5
Quality
2.1
Momentum
16.0
Dividend
—
Price
About Paragon Care Limited

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company distributes capital equipment, medical consumables, and online procurement solutions for hospitals, as well as offers pharmacy products, dispensary supplies, private label solutions, and digital ordering platforms to pharmacies, pharmacy groups, and hospital pharmacy services; medical consumables, nutrition supplies, aged care equipment, resident safety technology, and digital procurement solutions; and orthopedic implants, surgical technologies, and patient-focused solutions for orthopedic surgeons, hospitals, and healthcare providers. It also offers ophthalmic and optometry equipment, including diagnostic devices, OCT systems, slit lamps, dry eye treatment solutions, surgical instruments, and vision testing tools for eye care professionals and day surgery facilities; treatment room consumables, vaccines, diagnostic equipment, and infection prevention products for general practices, medical centres, and community healthcare providers; dental consumables, infection control supplies, dental equipment, imaging and technical support; laboratory equipment, scientific consumables, diagnostic instruments, and technical support; and diagnostic technologies, laboratory systems, and technical expertise. In addition, the company offers medical devices and clinical consumables; digital x-ray, ultrasound, molecular imaging, mobile c-arm, imaging navigation systems, and AI-driven software solutions; vitamins, supplements, herbal, and naturopathic products; veterinary consumables, pharmaceuticals, diagnostic equipment, and specialist clinical products; aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; and surgical robotics and robotic-assisted surgical systems hospitals and healthcare facilities. The company is based in Mount Waverley, Australia.

Price analytics

Returns

1 day 0.0%
1 week 3.7%
1 month 3.7%
3 months -6.7%
6 months -24.3%
1 year -51.7%
3 years -24.3%

Risk

Volatility (1y ann.) 61.6%
Beta vs ASX 200 0.34
Sharpe (1y) -0.94
VaR 95% (1-day) -7.0%
Max drawdown (1y) -61.5%
Off 1-year high -56.9%

Technicals

RSI(14) 75 OB
vs 50DMA 3.7%
vs 200DMA -15.6%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 68.8
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
0
Price / Book
100
Price / Sales
100
Growth 50.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health 13.5
Net debt / EBITDA
0
Interest coverage (EBIT/interest)
8
Current ratio
5
Debt / Equity
38
Quality (Profitability & Cash Flow) 2.1
Return on equity
0
Return on assets
3
Operating margin
6
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 16.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
69
Position in 52-week range
8

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$231.74M
P/E (trailing)
—
P/E (forward)
6.09
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
-0.28
EV / EBITDA
23.20
Price / Book
0.78
ROE
-5.1%
Operating margin
1.5%
Net margin
-0.4%
Total cash
$23.68M
Total debt
$388.90M
Current ratio
0.89
Debt / Equity
1.31
Free cash flow
$19.06M
Avg volume
435,946
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$2.97B
  • Gross profit$176.53M
  • Operating income$28.44M
  • Net income$8.38M
  • Diluted EPS0.01
  • Free cash flow$33.08M
  • Net debt$414.47M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4